Skip to content

Maternal Expectations on Labor Analgesia and Risk of Postpartum Depression: An Observational Study

Maternal Expectations on Labor Analgesia and Risk of Postpartum Depression: An Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07292649
Enrollment
3640
Registered
2025-12-18
Start date
2026-01-08
Completion date
2029-06-01
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Expectations, Labor Analgesia, Postpartum Depression (PPD)

Keywords

postpartum depression, labor analgesia, epidural, expectations

Brief summary

Postpartum Depression (PPD) is defined as the development of depression at any time during the first year after childbirth¹. Its prevalence ranges from 15% to 20%. It can manifest with symptoms such as depressed mood, loss of interest and energy, insomnia, anxiety, and may even lead to suicidal ideation. The consequences are numerous, both physical and psychological, with long-term repercussions on the mother-infant bond, family dysfunction, and the development of emotional and cognitive disorders in children. The etiology of PPD is multifactorial, but numerous recent studies have focused on the role of labor pain and its management with labor analgesia techniques. The aim of the present study is therefore to assess whether there is a difference in the incidence of PPD between parturients whose expectations regarding labor analgesia were met ('expectations met' group) versus those whose expectations were unmet.

Interventions

PROCEDUREEpidural analgesia

Analgesia via epidural catheter using local anesthetic ± opioid, administered on patient request during labor.

Single-shot spinal analgesia

OTHERNo neuraxial analgesia

Patients did not received spinal or epidural labour analgesia

Sponsors

University of Padova
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Signed informed consent * Planned vaginal delivery (spontaneous or induced) * Pregnancy * Age \> 18 years

Exclusion criteria

* Allergy to local anesthetics * Language barrier * Contraindications to labor analgesia * Delivery by Cesarean section * Known history of psychiatric disorders (including major depression)

Design outcomes

Primary

MeasureTime frameDescription
incidence of postpartum depression6 months since labourTo assess whether there is a statistically significant difference in the incidence of postpartum depression (PPD), defined as an Edinburgh Postnatal Depression Scale (EPDS) score ≥ 10 at 6 months postpartum, between parturients whose expectations regarding labor analgesia were met ('expectations met' group) versus those whose expectations were unmet.

Secondary

MeasureTime frameDescription
Early depressive symptomsfrom 24 to 48 hours since labourTo assess whether there is a statistically significant difference in the incidence of postpartum depression (PPD), defined as an Edinburgh Postnatal Depression Scale (EPDS) score ≥ 10 at 6 months postpartum, between parturients whose expectations regarding labor analgesia were met ('expectations met' group) versus those whose expectations were unmet.
Effect of Analgesia Within Expectations-Unmet Groupsix months since labourTo compare the incidence of postpartum depression (EPDS ≥ 10 at 6 months) within the "Expectations unmet" group, stratified by actual receipt of neuraxial labor analgesia (epidural or spinal) versus no neuraxial analgesia
Pain Intensity and Maternal ExpectationsAt delivery/birthTo assess the association between intrapartum pain intensity (measured by Visual Analog Scale, VAS) and group allocation ("Expectations met" vs "Expectations unmet").

Countries

Italy

Contacts

CONTACTFabrizia Calabrese, MD
fabrizia.calabrese@aopd.veneto.it+39 0498213090
CONTACTGiulia Faccioli, MD
giuliafdg@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026